Decline in immunity to polio among young adults.

[1]  Y. Manor,et al.  Detection of Poliovirus Circulation by Environmental Surveillance in the Absence of Clinical Cases in Israel and the Palestinian Authority , 1999, Journal of Clinical Microbiology.

[2]  A. Leventhal,et al.  Immune response to an intercalated enhanced inactivated polio vaccine/oral polio vaccine programme in Israel: impact on the control of poliomyelitis. , 1998, Vaccine.

[3]  B. Kaić,et al.  Immunity of the Croatian population to poliomyelitis--a serosurvey. , 1998, Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti.

[4]  G. Fara,et al.  Immunity status against poliomyelitis in persons 13-14 years old living in Rome. , 1997, Vaccine.

[5]  P. Rhodes,et al.  Outbreak of paralytic poliomyelitis in a highly immunized population in Jordan. , 1997, The Journal of infectious diseases.

[6]  M. Pallansch,et al.  Outbreak of poliomyelitis in Gizan, Saudi Arabia: cocirculation of wild type 1 polioviruses from three separate origins. , 1997, The Journal of infectious diseases.

[7]  C. Chezzi,et al.  Outbreak of paralytic poliomyelitis in Namibia , 1994, The Lancet.

[8]  D. Cohen,et al.  Four-year follow-up of the immune status of young adults given a single booster dose of trivalent oral poliovaccine. , 1994, Vaccine.

[9]  D. Cohen,et al.  Age differences in immunity against wild and vaccine strains of poliovirus prior to the 1988 outbreak in Israel and response to booster immunization. , 1993, Vaccine.

[10]  R. Handsher,et al.  Israel in the elimination phase of poliomyelitis--achievements and remaining problems. , 1993, Public health reviews.

[11]  M. Deming,et al.  Epidemic poliomyelitis in The Gambia following the control of poliomyelitis as an endemic disease. II. Clinical efficacy of trivalent oral polio vaccine. , 1992, American journal of epidemiology.

[12]  M. Deming,et al.  Epidemic poliomyelitis in The Gambia following the control of poliomyelitis as an endemic disease. I. Descriptive findings. , 1992, American journal of epidemiology.

[13]  S. Lo Caputo,et al.  Seroimmunity to poliomyelitis in an Albanian immigrant population. , 1992, Vaccine.

[14]  D. Cohen,et al.  Sociodemographic correlates of neutralizing poliovirus and hepatitis A virus antibodies as markers of different modes of acquiring immunity. , 1990, American journal of public health.

[15]  Manfred S. Green,et al.  Poliomyelitis outbreak in Israel in 1988: a report with two commentaries , 1990, The Lancet.

[16]  A. Morag,et al.  Antibodies to polioviruses in an Israeli population and Overseas volunteers , 1990, Journal of medical virology.

[17]  P. White,et al.  Prevalence of antibody to poliovirus in England and Wales 1984-6. , 1986, British medical journal.

[18]  J. Salk,et al.  Standardization of poliovirus neutralizing antibody tests. , 1984, Reviews of infectious diseases.

[19]  N. Goldblum,et al.  Comparison of inactivated poliovirus vaccine and oral poliovirus vaccine programs in Israel. , 1984, Reviews of infectious diseases.

[20]  E. Collins,et al.  CHILDHOOD IMMUNIZATION 1979 DISTURBING STATISTICS FOR METROPOLITAN SYDNEY , 1980, The Medical journal of Australia.

[21]  S. Halstead,et al.  Oral polio vaccine. Effect of booster vaccination one to 14 years after primary series , 1978 .